Log in

ELAB PMGC Holdings Inc. NASDAQ · United States

PMGC Holdings (ELAB) news

PMGC Holdings Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ELAB, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest PMGC Holdings news

We have not published a story on PMGC Holdings yet. When there is news, it will appear here.

PMGC Holdings annual financials

LineFY2025FY2024
Revenue$590,084
Research and development$147,010$104,654
Net income (loss)-$7.7 million-$6.2 million
Cash from operations-$5.9 million-$5.5 million
Cash and equivalents$5.4 million$4.0 million
Short-term investments$572,054

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $18.1 million, plus short-term investments of $650,598, $18.8 million in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about PMGC Holdings

What is the ticker symbol of PMGC Holdings?

PMGC Holdings Inc. trades under the ticker ELAB on NASDAQ.

Where is PMGC Holdings listed?

PMGC Holdings Inc. is listed on NASDAQ.

Which country or territory is PMGC Holdings listed under?

Our directory records PMGC Holdings Inc. under United States.

Does aibio.space cover PMGC Holdings?

aibio.space lists PMGC Holdings Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was PMGC Holdings's revenue last year?

$590,084 for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is PMGC Holdings profitable?

PMGC Holdings Inc. reported a net loss of $7.7 million for the fiscal year ended Dec 31, 2025, and used $5.9 million of cash in operations, per its annual report to the SEC.

How much does PMGC Holdings spend on research and development?

$147,010 in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does PMGC Holdings have?

$18.8 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.

Investor discussion: PMGC Holdings

Members talk about PMGC Holdings (ELAB). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at PMGC Holdings, newest first. Each line links the filing it comes from.

  1. Listings

    Reported a reverse stock split. SEC Form 8-K (Items 1.01,3.03,5.03,7.01,8.01,9.01). Source

  2. Mergers

    Reported a merger or acquisition agreement. SEC Form 8-K (Items 1.01,9.01). Source

  3. Mergers

    Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 1.01,2.01,7.01,9.01). Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:ELAB on TradingView.

Listing details

PMGC Holdings Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ELAB, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
PMGC Holdings Inc.
Ticker
ELAB
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.